Psychedelic research: evaluating the regulatory roadmap

Aman Khera and Dr Christine Moore of Worldwide Clinical Trials share how regulatory agencies are supporting psychedelic research.

Related Keywords

United States ,Canada ,Netherlands ,United Kingdom ,America ,Dutch ,Christine Moore ,Aman Khera ,European Medicine Agency Adaptive Pathway ,Drug Administration ,Contract Research Organisations Cros ,Scientific Solutions ,Health Technology Assessment ,Regulatory Agency ,European Monitoring Centre For Drugs ,Approval Program ,Substances Act When Conducting Clinical Research ,European Medicines Agency ,Health Canada ,Worldwide Clinical Trials ,United Kingdom Medicines ,North America ,Innovation Passport Designation ,Innovative Licensing ,Access Pathway ,Priority Medicines ,Contract Research Organisations ,Trial Regulation ,Clinical Trial ,Global Head ,Regulatory Strategy ,Worldwide Clinical ,Vice President ,Monitoring Centre ,Drug Addiction ,Drug Regulations ,Controlled Drugs ,Medicines Agency ,European Medicine Agency ,Adaptive Pathway ,European Medicines ,Asked Questions ,Track Designation ,